MyChesCo on MSN

AstraZeneca and Amgen Secure FDA Approval for TEZSPIRE to Treat Chronic Rhinosinusitis with Nasal Polyps

AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents aged 12 and ...

Doctors Warn Against This Common Cold Remedy Mistake That Can Make Symptoms Worse

Fall and winter are the most common times of year for the common cold. Signs of the common cold include sneezing, a runny ...